Literature DB >> 498709

Interindividual variation in kinetics of infused epinephrine.

G A FitzGerald, V Hossmann, C A Hamilton, J L Reid, D S Davies, C T Dollery.   

Abstract

1-Norepinephrine was infused continuously for 10 hr into 5 normotensive, male laboratory subjects (mean age, 32.4 +/- 1.9 yr) at a mean rate of 0.06 microgram/kg/min. Mean plasma norepinephrine (NE) rose from the preinfusion level of 0.19 +/- 0.02 microgram/l to a steady state level of 1.22 +/- 0.29 microgram/l. The mean increase in blood pressure was 21.8 +/- 0.9 mm Hg systolic and 14.1 +/- 1.0 mm Hg diastolic. The mean depression in heart rate was 12.7 +/- 1.7 beats/min. The clearance of norepinephrine ranged from 27.9 to 100.0 ml/kg/min (mean. 58.0 +/- 13.8) and was little influenced by acute hemodynamic changes. The volume of distribution ranged widely (0.09 to 0.40 l/kg), the mean value being 13.51 1. The mean norepinephrine half-life was brief, ranging from 1.45 to 2.9 min (mean, 2.09 +/- 0.34 min). There was no evidence of a slowly accumulating high-capacity low-affinity pool of norepinephrine. These results support the use of plasma norepinephrine as an index of sympathetic activity within an individual but not its validity in interindividual comparisons.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498709     DOI: 10.1002/cpt1979266669

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stress.

Authors:  J Hilsted; N J Christensen; S Madsbad
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

2.  Pharmacodynamic and pharmacokinetic evaluation in man of the new sympathomimetic amezinium.

Authors:  G Neugebauer; H S Kaumeier; O H Kehrhahn; H Morgenthaler
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Tolerance to the humoral and hemodynamic effects of caffeine in man.

Authors:  D Robertson; D Wade; R Workman; R L Woosley; J A Oates
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

Review 4.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

5.  Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentrations and their dissipation profile.

Authors:  A Ohnishi; A Minegishi; T Sasaki; T Suganuma; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

6.  Relationship between arterial and peripheral venous catecholamine plasma catecholamine concentrations during infusion of noradrenaline and adrenaline in healthy volunteers.

Authors:  H Ensinger; T Weichel; K H Lindner; A Prengel; A Grünert; F W Ahnefeld
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Plasma concentrations of free and sulfoconjugated dopamine, epinephrine, and norepinephrine in healthy infants and children.

Authors:  I Eichler; H G Eichler; M Rotter; P A Kyrle; S Gasic; A Korn
Journal:  Klin Wochenschr       Date:  1989-07-03

8.  Inability to demonstrate physiologic correlates of subjective improvement among patients taught the relaxation response.

Authors:  D M Eisenberg; L Landsberg; E N Allred; R B Saper; T L Delbanco
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.